Quarterly Result4 Aug 2026, 04:20 pm
Shree Ganesh Biotech Declares Un-audited Q1 FY27 Results
AI Summary
Shree Ganesh Biotech (India) Ltd announced that its Board of Directors, in a meeting held on August 4, 2026, considered and approved the un-audited standalone financial results for the quarter ended June 30, 2026. The financial results were reviewed by the Audit Committee and have undergone a limited review by the statutory auditors. The company operates in a single segment.
Key Highlights
- Board approved un-audited standalone financial results for Q1 FY27.
- Results for the quarter ended June 30, 2026, were declared.
- Financial results were reviewed by the Audit Committee.
- Statutory Auditors conducted a limited review.
- Company has only one business segment.
Price Impact
More from SHREEGANES